Public Profile

Piramal Pharma Limited

Piramal Pharma Limited, a prominent player in the global pharmaceutical industry, is headquartered in India and operates extensively across key regions, including North America, Europe, and Asia. Founded in 1988, the company has achieved significant milestones, establishing itself as a leader in both contract development and manufacturing, as well as in the formulation of complex generics. Piramal Pharma's core offerings include a diverse range of pharmaceutical products and services, with a strong emphasis on innovative drug delivery systems and advanced therapies. Their commitment to quality and sustainability sets them apart in a competitive market. With a robust portfolio and a focus on research and development, Piramal Pharma Limited continues to enhance its market position, contributing to healthcare solutions worldwide.

DitchCarbon Score

How does Piramal Pharma Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

21

Industry Average

Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

14

Industry Benchmark

Piramal Pharma Limited's score of 21 is higher than 97% of the industry. This can give you a sense of how well the company is doing compared to its peers.

97%

Piramal Pharma Limited's reported carbon emissions

In 2023, Piramal Pharma Limited reported total greenhouse gas emissions of approximately 56230000 kg CO2e for Scope 1, 79415000 kg CO2e for Scope 2, and a significant 499659000 kg CO2e for Scope 3 emissions. This data highlights the company's substantial carbon footprint across its operations. Piramal Pharma has set ambitious climate commitments, aiming to reduce its absolute Scope 1 and 2 greenhouse gas emissions by 42% by FY2030, using FY2022 as the baseline year. Additionally, the company targets a 25% reduction in absolute Scope 3 emissions, which encompass emissions from purchased goods and services, fuel and energy-related activities, upstream transportation and distribution, and the use of sold products, also by FY2030. These targets align with industry standards and reflect Piramal Pharma's commitment to addressing climate change and reducing its environmental impact. The company has not yet committed to a net-zero target but is actively working towards significant emissions reductions in the near term.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

20222023
Scope 1
55,229,000
00,000,000
Scope 2
75,494,000
00,000,000
Scope 3
450,639,000
000,000,000

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Piramal Pharma Limited's primary industry is Chemicals nec, which is medium in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. Piramal Pharma Limited is headquartered in IN, which has a rank of very high, indicating very high grid carbon intensity.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Piramal Pharma Limited is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero

Was this information valuable to you?

Similar Organizations

Laurus Labs

IN
Medical, precision and optical instruments, watches and clocks (33)
Updated about 20 hours ago

Abbott

US
Medical, precision and optical instruments, watches and clocks (33)
Updated 5 days ago

Abbott India Limited

IN
Chemicals nec
Updated about 2 months ago
DitchCarbon Score

Sun Pharmaceutical Industries

IN
Medical, precision and optical instruments, watches and clocks (33)
Updated about 20 hours ago

Emami

IN
Retail trade services, except of motor vehicles and motorcycles; repair services of personal and household goods (52)
Updated 5 days ago

Dabur

IN
Retail trade services, except of motor vehicles and motorcycles; repair services of personal and household goods (52)
Updated 11 minutes ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers